Pantoprazole Sodium
NDC Package 0008-0607-01

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Other Packages
    3. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Pantoprazole Sodium is pantoprazole is used to treat certain stomach and esophagus problems (such as acid reflux). Marketed by Wyeth Pharmaceuticals Inc., A Subsidiary Of Pfizer Inc., this product is identified by NDC 0008-0607 and is authorized under FDA application NDA020987.

Identification & Billing

NDC Package Code
0008-0607-01
Package Description
90 TABLET, DELAYED RELEASE in 1 BOTTLE
Product Code
0008-0607
11-Digit Billing Format
00008060701
Billing Unit
EA - Billing unit of "each" is used when the product is dispensed in discreet units.
Units Per Package
90 EA

Clinical Specifications

Proprietary Name
Pantoprazole Sodium Delayed-release
Dosage Form
-
Usage Information
Pantoprazole is used to treat certain stomach and esophagus problems (such as acid reflux). It works by decreasing the amount of acid your stomach makes. This medication relieves symptoms such as heartburn, difficulty swallowing, and persistent cough. It helps heal acid damage to the stomach and esophagus, helps prevent ulcers, and may help prevent cancer of the esophagus. Pantoprazole belongs to a class of drugs known as proton pump inhibitors (PPIs).

Regulatory & Marketing

Labeler Name
Wyeth Pharmaceuticals Inc., A Subsidiary Of Pfizer Inc.
FDA Application #
NDA020987
Marketing Category
NDA - A product marketed under an approved New Drug Application.
Start Marketing Date
01-31-2008
End Marketing Date
10-31-2017
Listing Expiration
10-31-2017
Exclude Flag
D
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (0008-0607). Click a package code to view its specific billing and regulatory data.

0008-0607-04
100 BLISTER PACK in 1 CARTON / 1 TABLET, DELAYED RELEASE in 1 BLISTER PACK

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 0008-0607-01 identifies a specific commercial package of 90 tablet, delayed release in 1 bottle of Pantoprazole Sodium Delayed-release, labeled by Wyeth Pharmaceuticals Inc., A Subsidiary Of Pfizer Inc.. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Wyeth Pharmaceuticals Inc., A Subsidiary Of Pfizer Inc. on January 31, 2008. The current certification is valid through October 31, 2017.

What are the primary indications for this medication?

Pantoprazole is used to treat certain stomach and esophagus problems (such as acid reflux). It works by decreasing the amount of acid your stomach makes. This medication relieves symptoms such as heartburn, difficulty swallowing, and persistent cough. It helps heal acid damage to the stomach and esophagus, helps prevent ulcers, and may help prevent cancer of the esophagus. Pantoprazole belongs to a class of drugs known as proton pump inhibitors (PPIs).

How is this Wyeth Pharmaceuticals Inc., A Subsidiary Of Pfizer Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 00008060701. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 90 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (4-4-2)
0008-0607-01
11-Digit CMS (5-4-2)
00008-0607-01

Note: The zero is added to the Labeler segment to maintain the 5-4-2 structure.